QA

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments. SMS was given the export house status in the year 1997-98. SMS is currently a listed company having ever appreciating international and domestic customer base.

Marksans Pharma, headquartered at Mumbai (India) is a global pharmaceutical company. We are actively engaged in R&D and offer CRAMS to global pharmaceutical companies. Marksans Pharma have established world-class manufacturing facilities by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliances. Our plants are approved by prestigious US FDA, UK MHRA, Australian TGA and other foreign health authorities.

Pharmaceuticals & Medical Devices Bureau of India (PMBI) is the implementing agency of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP). PMBI was established in December, 2008 under the Department of Pharmaceuticals, Government of India. The Bureau has been registered as an independent society under the Societies Registration Act, 1860 as a separate independent legal entity in April, 2010. PMBI follows the provisions of GFR. 2017 as amended from time to time, the CVC guidelines, and instructions from the Department of Pharmaceuticals.

MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar.

Quality Assurance OSD Department - Formulation Division

Post : Trainee | Executive | Sr. Executive

Optimus was established in the year 2004 as custom synthesis laboratory by a team of Technocrats. It is one of the fastest growing Manufacturer in Active Pharmaceutical Ingredients (APIs) and Finished dosages. We expanded into global markets and started filing DMFs for both APIs and Intermediates with various Regulatory agencies. Optimus Research Center for API & Formulations was set-up as a centralized Research and Development center to focus on Generic product developments suitable for regulated markets.

Jodas is a Global, specialty, innovation driven, emerging, generic bio- pharmaceutical company, that is asserting itself among the worlds foremost pharmaceutical companies. JEPL is having EU GMP certification of Oncology (orals), Contrast Media (SVP and LVP) and facility for Cephalosporins currently delivering the products like Anti-Cancer and Antibiotics.

Ajanta Pharma Limited, a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. Ajanta operates 7 state-of-the-art manufacturing facilities in India. 2 of the facilities in India have been successfully approved by USFDA.

Otsuka Pharmaceutical India Private Limited is a Joint Venture between Otsuka Pharmaceutical Factory, Inc., Japan and Mitsui & Co. Ltd., Japan, for Infusion Business in India and Emerging Markets. We primarily manufacture & market products across multiple markets and therapeutic segments. Being a leader in intravenous nutrition products, we are committed to being the best partner of patients and healthcare professionals in the field of clinical nutrition.

Jodas is a Global, specialty, innovation driven, emerging, generic bio- pharmaceutical company, that is asserting itself among the worlds foremost pharmaceutical companies. JEPL is having EU GMP certification of Oncology (orals), Contrast Media (SVP and LVP) and facility for Cephalosporins currently delivering the products like Anti-Cancer and Antibiotics, Contrast media.